Developing home-care hospitalization: Cost evaluation and assessment criteria. The case of anticancer chemotherapy;Développer l'hospitalisation à domicile: À quels coûts, selon quel cadre d'évaluation? Le cas des chimiothérapies antinéoplasiques

Revue d'Epidemiologie et de Sante Publique

Volumn 51, Issue 6, 2003, Pages 649-652

  Remonnay, R ^a,b   Devaux, Y ^a   Chauvin, F ^a,b   Dubost, E ^c   Carrere M O ^b  

^a CENTRE LÉON BÉRARD   (France)

^b UNIVERSITÉ LYON 1   (France)

^c Association Soins et Sante

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CYTOSTATIC AGENT;

ARTICLE; CANCER; CANCER CHEMOTHERAPY; COST EFFECTIVENESS ANALYSIS; DRUG COST; HOME CARE; HOSPITALIZATION; HUMAN;

ANTINEOPLASTIC AGENTS; COST-BENEFIT ANALYSIS; FEMALE; FRANCE; HEALTH PERSONNEL; HOME CARE SERVICES, HOSPITAL-BASED; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES;

EID: 0842264298     PISSN: 03987620     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Coast J, Hensher M, Mulligan JA, Shepperd S, Jones J. Conceptual and practical difficulties with the economic evaluation of health services developments. J Health Serv Res Policy 2000; 5: 42-8.
2. Shepperd S, Ilife S. The effectiveness of hospital at home compared with in-patient hospital care: a systematic review. J Public Health Med 1998; 20: 344-50.
3. Com-Ruelle L, Raffy N. L'hospitalisation à domicile en 1992. Méthodologie et variables observées. Paris: CREDES; 1992.
4. Ministère de l'Emploi et de la Solidarité. Circulaire DH/EO2/2000/295 relative à l'hospitalisation à domicile. Paris: Bulletin officiel, 2000.
5. Ministère de l'Emploi et de la Solidarité. L'hospitalisation à domicile en France: bilan et propositions. Rapport du Groupe de travail, coordonné par la direction des hôpitaux. Paris: 1999.
6. Remonnay R, Devaux Y, Chauvin F, Dubost E, Carrère MO. Economic evaluation of antineoplasic chemotherapy administered at home or in hospitals. Int J Technol Assess Health Care 2002; 18: 508-19.
7. Lowenthal RM, Piaszczyk A, Arthur GE, O'Malley S. Home chemotherapy for cancer patients: cost analysis and safety. Med J Aust 1996; 165: 184-7.
8. Rischin D, White MA, Matthews JP, Toner GC, Watty K. A randomised crossover trial of chemotherapy in the home: patient preferences and costs analysis. Med J Aust 2000; 173: 125-7.
9. King MT, Hall J, Caleo S, Gurney HP, Harnett PR. Home or hospital? An evaluation of the costs, preferences and outcomes of domiciliary chemotherapy. Int J Health Serv 2000; 30: 557-79.
10. Commission d'Orientation sur le Cancer. Rapport. Ministère de la Santé, de la Famille et des Personnes Handicapées. http://www.sante.gouv.fr/htm/dossiers/cancer/index.htm. 2003; p. 336.